Online resource launched to empower people with vulval lichen sclerosus

As­cen­t­age Phar­ma, a Hong Kong-list­ed blood can­cer biotech, is plan­ning a dual list­ing in the US as it pre­pares for ad­di­tion­al drug launch­es, it …

A new Bris­tol My­ers Squibb cell man­u­fac­tur­ing site that is ex­pect­ed to make the CAR-T ther­a­py Breyanzi has re­ceived FDA ap­proval to start pro­duc­tion. The